ED Hypernatremia. Prognostic Factors and Epidemiology.

Centre Hospitalier Universitaire de Besancon250 enrolled

Overview

This study evaluate the 1-month mortality of patients who proceed a blood sample while in the ED with an hypernatremia (\>145 mmol/l). This prospective study will try to show several prognostic factors, and show the epidemiology of hypernatremia in this single center evaluation.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Hypernatremia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Natremia \> 145 mmol/l Exclusion Criteria: * Age \< 18 years * Refusal

Locations (1)

CHU Besançon

Besançon, France

RECRUITING

Outcomes

Primary Outcomes

one month survival

Survival at 1 month after the blood sample at the ED

Time frame: 1 month

Central Contacts

Romain ADAM, Resident

CONTACT

+33646470168 radam@chu-besancon.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.